Zafrilla 2mg tablets
*Company:
Gedeon Richter IrelandStatus:
UpdatedLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 11 September 2024
File name
Zafrilla 2mg tbl_SmPC_en_PA1330-023-001.pdf
Reasons for updating
- Change to section 9 - Date of first authorisation/renewal of the authorisation
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 06 February 2023
File name
Zafrilla 2mg tbl_SmPC_en_PA1330-023-001.pdf
Reasons for updating
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 25 November 2022
File name
Zafrilla 2mg tbl_SmPC_en_PA1330-023-001.pdf
Reasons for updating
- Change to section 6.3 - Shelf life
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 20 August 2021
File name
Zafrilla PIL 20 Aug 2021.pdf
Reasons for updating
- New PIL for new product
Updated on 20 August 2021
File name
Zafrilla SmPC 20 Aug 2021.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)